Results from phase 3 trial show baricitinib reduces deaths from COVID-19

The latest results from a study to assess the efficacy of the arthritis drug, baricitinib, in treating COVID-19 patients have shown that the treatment reduced mortality in those hospitalized with the disease.

Share:

Facebook
Twitter
Pinterest
LinkedIn

Leave a Reply

Related Posts

Vitamins and Minerals

Vitamins and minerals are micronutrients required by the body to carry out a range of normal functions. However, these micronutrients are not produced in our